Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
- PMID: 35359156
- PMCID: PMC8968880
- DOI: 10.3324/haematol.2021.279649
Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
Comment on
-
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.Haematologica. 2022 Apr 1;107(4):1008-1010. doi: 10.3324/haematol.2021.279535. Haematologica. 2022. PMID: 34382388 Free PMC article. No abstract available.
References
-
- World Health Organization. Global manual on surveillance of adverse effect following immunization. 2015 Update. World Health Organization. 2014.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
